ES8404346A1 - Un procedimiento para la preparacion de diarilpirazinas o triazinas. - Google Patents

Un procedimiento para la preparacion de diarilpirazinas o triazinas.

Info

Publication number
ES8404346A1
ES8404346A1 ES520340A ES520340A ES8404346A1 ES 8404346 A1 ES8404346 A1 ES 8404346A1 ES 520340 A ES520340 A ES 520340A ES 520340 A ES520340 A ES 520340A ES 8404346 A1 ES8404346 A1 ES 8404346A1
Authority
ES
Spain
Prior art keywords
triazine
pyrazine derivatives
pyrazine
derivatives
diarylpyrazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520340A
Other languages
English (en)
Other versions
ES520340A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES520340A0 publication Critical patent/ES520340A0/es
Publication of ES8404346A1 publication Critical patent/ES8404346A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/16—Halogen atoms; Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DIARILPIRAZINAS O TRIAZINAS Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R1 Y R2 SON ALQUILO C1-3 O CLORO; X ES NITROGENO O CH; Q ES OXIGENO O -(CH2)N- DONDE N VALE 0-2 Y W PUEDE SER VARIOS RADICALES.CONSISTE EN LA REACCION DE SUSTITUCION NUCLEOFILICA DE UN COMPUESTO DE FORMULA (II) CON UNA AMINA DE FORMULA (III), EN LAS QUE R3 ES UN GRUPO CAPAZ DE SER SUSTITUIDO Y LOS DEMAS SIMBOLOS TIENEN LOS MISMOS SIGNIFICADOS QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE O EN SUAUSENCIA, EN PRESENCIA DE UNA BASE A UNA TEMPERATURA ENTRE 80JC Y 150JC.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ACTIVANTES DE LA UNION DEL ACIDO GAMMA-AMINOBUTIRICO Y LA BENZODIAZEPINA EN EL SISTEMA NERVIOSO CENTRAL.
ES520340A 1982-03-05 1983-03-04 Un procedimiento para la preparacion de diarilpirazinas o triazinas. Expired ES8404346A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/354,982 US4513135A (en) 1982-03-05 1982-03-05 Diaryl-pyrazine derivatives affecting GABA binding

Publications (2)

Publication Number Publication Date
ES520340A0 ES520340A0 (es) 1984-04-16
ES8404346A1 true ES8404346A1 (es) 1984-04-16

Family

ID=23395746

Family Applications (2)

Application Number Title Priority Date Filing Date
ES520340A Expired ES8404346A1 (es) 1982-03-05 1983-03-04 Un procedimiento para la preparacion de diarilpirazinas o triazinas.
ES526297A Expired ES8504173A1 (es) 1982-03-05 1983-10-06 Un procedimiento para la preparacion de diarilpirazinas o triazinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES526297A Expired ES8504173A1 (es) 1982-03-05 1983-10-06 Un procedimiento para la preparacion de diarilpirazinas o triazinas

Country Status (22)

Country Link
US (2) US4513135A (es)
EP (1) EP0088593B1 (es)
JP (1) JPS58162582A (es)
KR (1) KR860000847B1 (es)
AT (1) ATE27457T1 (es)
AU (1) AU547581B2 (es)
CA (1) CA1195327A (es)
DD (1) DD207716A5 (es)
DE (1) DE3371786D1 (es)
DK (1) DK97283A (es)
ES (2) ES8404346A1 (es)
FI (1) FI830708L (es)
GB (1) GB2116179B (es)
GR (1) GR78459B (es)
HU (1) HU191368B (es)
IL (1) IL68002A (es)
NZ (1) NZ203428A (es)
PH (1) PH22535A (es)
PL (1) PL240871A1 (es)
PT (1) PT76312B (es)
RO (1) RO86320B (es)
ZA (1) ZA831387B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
JPH06501926A (ja) * 1990-08-06 1994-03-03 藤沢薬品工業株式会社 複素環式化合物
GB9420010D0 (en) * 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
TWI316055B (es) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
KR100490893B1 (ko) * 2002-10-11 2005-05-23 (주) 비엔씨바이오팜 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US20070003394A1 (en) * 2005-02-01 2007-01-04 Carey Paul G Anti-cross threading fastener
TW200716594A (en) * 2005-04-18 2007-05-01 Neurogen Corp Substituted heteroaryl CB1 antagonists
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
DK2531492T3 (en) * 2010-02-05 2016-07-04 Heptares Therapeutics Ltd 1,2,4-triazin-4-amine derivatives
GB201106829D0 (en) 2011-04-21 2011-06-01 Proximagen Ltd Heterocyclic compounds
TW201321353A (zh) * 2011-10-08 2013-06-01 Novartis Ag 胺基甲酸酯／尿素衍生物
SG11201900157RA (en) * 2016-07-12 2019-02-27 Revolution Medicines Inc 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
JP6918828B2 (ja) * 2016-11-30 2021-08-11 田辺三菱製薬株式会社 トリアジン化合物の製造方法
MX2019008696A (es) 2017-01-23 2019-09-13 Revolution Medicines Inc Compuestos de piridina como inhibidores de shp2 alostericos.
CN117327075A (zh) 2017-01-23 2024-01-02 锐新医药公司 作为变构shp2抑制剂的二环化合物
BR112020004246A2 (pt) 2017-09-07 2020-09-01 Revolution Medicines, Inc. composições inibidoras de shp2 e métodos para o tratamento de câncer
WO2019075265A1 (en) 2017-10-12 2019-04-18 Revolution Medicines, Inc. PYRIDINE, PYRAZINE AND TRIAZINE COMPOUNDS AS ALLOSTERIC INHIBITORS OF SHP2
BR112020009757A2 (pt) 2017-12-15 2020-11-03 Revolution Medicines, Inc. compostos policíclicos como inibidores alostéricos de shp2
EP3788050B1 (en) 2018-05-01 2024-08-28 Revolution Medicines, Inc. C26-linked rapamycin analogs as mtor inhibitors
IL300091A (en) 2018-05-01 2023-03-01 Revolution Medicines Inc C40-, C28-, and C-32-linked rapamycin analogs as MTOR inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172889A (en) * 1965-03-09 Process for the separation of z-methyl-
US3294638A (en) * 1961-06-05 1966-12-27 Warner Lambert Pharmaceutical Method and compositions employing 2-alkyl-3-piperidinopyrazines
CH480795A (de) * 1967-03-01 1969-11-15 Sandoz Ag Mittel zur Beeinflussung des Pflanzenwachstums
US4013654A (en) * 1974-01-31 1977-03-22 Eli Lilly And Company 5,6-diaryl-1,2,4-triazines
US3948894A (en) * 1974-01-31 1976-04-06 Eli Lilly And Company 3-Amino-5,6-diaryl-1,2,4-triazines
US3979516A (en) * 1974-01-31 1976-09-07 Eli Lilly And Company Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines
US3989831A (en) * 1974-01-31 1976-11-02 Eli Lilly And Company Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines
US4081542A (en) * 1975-04-21 1978-03-28 Merck & Co., Inc. Piperazinylpyrazines
GB1493998A (en) * 1975-06-03 1977-12-07 Beecham Group Ltd Propanolamine derivatives
US4008232A (en) * 1975-06-23 1977-02-15 Eli Lilly And Company 3-Amino-5,6-diaryl-1,2,4-triazines
US4082844A (en) * 1976-02-09 1978-04-04 Merck & Co., Inc. 6-chloro-2-(1-piperazinyl)pyrazine
US4021553A (en) * 1976-03-10 1977-05-03 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
US4018923A (en) * 1976-03-10 1977-04-19 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents
US4190725A (en) * 1976-03-10 1980-02-26 Eli Lilly And Company 5,6-Diaryl-1,2,4-triazines
NL7802514A (nl) * 1977-03-09 1978-09-12 Fabre Sa Pierre 5,6-diaryl-1,2,4-triazinederivaten en werkwijze ter bereiding van deze verbindingen.
US4251527A (en) * 1977-05-17 1981-02-17 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
US4157392A (en) * 1977-05-17 1979-06-05 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
DE2821381A1 (de) * 1977-05-17 1978-11-30 Diamond Shamrock Corp Substituierte 1,2,4-triazine und sie enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
NZ203428A (en) 1986-09-10
IL68002A (en) 1986-09-30
PT76312B (en) 1986-02-04
ATE27457T1 (de) 1987-06-15
ZA831387B (en) 1984-10-31
DE3371786D1 (en) 1987-07-02
HU191368B (en) 1987-02-27
IL68002A0 (en) 1983-06-15
FI830708A0 (fi) 1983-03-02
EP0088593A2 (en) 1983-09-14
DK97283A (da) 1983-09-06
ES526297A0 (es) 1985-04-16
RO86320B (ro) 1985-03-31
JPS58162582A (ja) 1983-09-27
GB2116179A (en) 1983-09-21
GB2116179B (en) 1985-09-11
CA1195327A (en) 1985-10-15
EP0088593B1 (en) 1987-05-27
US4513135A (en) 1985-04-23
PL240871A1 (en) 1984-06-18
AU1202983A (en) 1983-09-08
AU547581B2 (en) 1985-10-24
RO86320A (ro) 1985-03-15
GR78459B (es) 1984-09-27
ES8504173A1 (es) 1985-04-16
GB8305846D0 (en) 1983-04-07
ES520340A0 (es) 1984-04-16
KR860000847B1 (ko) 1986-07-09
PH22535A (en) 1988-10-17
KR840004101A (ko) 1984-10-06
EP0088593A3 (en) 1984-05-23
FI830708L (fi) 1983-09-06
DK97283D0 (da) 1983-02-28
DD207716A5 (de) 1984-03-14
PT76312A (en) 1983-04-01
US4585861A (en) 1986-04-29

Similar Documents

Publication Publication Date Title
ES8504173A1 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas
AU1574483A (en) Bismaleimide triazine composition
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
SU1089968A1 (ru) Магнитореологическая суспензия
ES8601849A1 (es) Un procedimiento para la preparacion de ariloxicicloalcanolaminoalquilen aril cetonas
SU1154938A1 (ru) Магнитореологическая суспензия
PL252065A1 (en) Method of obtaining 2,3,4,5-tetrahydro-1h-/1,4/diazepin /1,7-a/indoles
SU1083739A1 (ru) Стокс-калибратор
SU1256381A1 (ru) Способ переработки редкоземельного концентрата
SU1090131A1 (ru) Акселерометр
SU1122635A1 (ru) Спеченный композиционный материал
SU1241748A1 (ru) Способ разработки нефтяного месторождения
RO87212B1 (ro) Derivati de p-fluorbenzamida
SU1195570A1 (ru) Багажник-палатка крыши автомобиля
SU1086938A1 (ru) Способ голографической согласованной фильтрации
SU1089873A1 (ru) Способ крепления деталей в электрическом поле
SU1217054A1 (ru) Стокс-модулятор
SU1120886A1 (ru) P-i-n-ДИОД
SU1114135A1 (ru) Манотрон
SU1154903A1 (ru) Способ получения 2-имино-3-фенил-6-фенацилиден-2,3,5,6 -тетрагидро-1,3,4-оксадиазин-5-онов
SU1111454A1 (ru) Способ получения (4,6-дизамещенный пиримидинил-2)тиофанийбромидов
SU1187376A1 (ru) Подвеска транспортного средства
SU1018364A1 (ru) Способ получения п-толунитрила
SU1107561A1 (ru) Способ очистки нефтяного остаточного сырья
SU1216944A1 (ru) Способ получения 2,6-ди-трет-бутилфенола